Tag: Gene THerapy
East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures...
The newly raised funds will be utilized to enable several key initiatives like pre-clinical testing of CAR-NK and CAR-gamma delta T cell therapies
Cellevate raises €3.2 million in second seed round to drive global...
Biotech firm raises €6.6 million in total equity funding, gearing up the launch of its revolutionary Cellevat3d™ nanofiber microcarriers
Nucleome Informatics unveils DrSeq IRD panel for advanced diagnosis of retinal...
New genetic test set to transform early detection and treatment of Inherited Retinal Diseases with comprehensive analysis
Breakthrough gene therapy offers new hope for Glaucoma and Neurodegenerative diseases
Macquarie University develops gene therapy targeting tau protein, promising to prevent blindness and address conditions like Alzheimer’s
Miltenyi Biotec & THSTI collaborate to strengthen R&D in cell &...
This collaboration would help in capacity building, technology transfer, training programs, and joint research initiatives which would then be translated into medical therapies
IIT Kanpur & Reliance Life Sciences join forces to revolutionize gene...
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases, makes history by licensing gene therapy technology to an Indian biotech
US$ 10 billion oncology research to provide tailwinds to gene therapy...
Rising quest to search for breakthroughs in medical treatments have been fueling demand for gene therapy of various grades
Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis
The US$ 600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
First ever human patient dosed with Gene Therapy in Ocugen’s Phase...
This first patient dosing marks the beginning of the dose-escalating, observer-blind, Phase 1/2 safety and efficacy study
Bayer forays into gene therapy & digital health
Accelerating breakthrough innovation for patients, Bayer has a promising development portfolio with more than 50 projects in clinical development.....................